Preventive Medicine Doctors in Dearborn, MI Accepting Medicare

5 Preventive Medicine doctors found. Showing 1 - 5

Gregory H Zielinski, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 5050 Schaefer Rd, Dearborn, MI 48126 Phone: 313-581-2600    Fax: 313-581-0228

Dr. Eric S Stover, DO Preventive Medicine - Aerospace Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Schaefer Rd., Dearborn, MI 48126 Phone: 313-581-2600    Fax: 313-581-0228

Dr. Chandur Hiranand Karnani, M.D Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 5050 Schaefer Rd, Dearborn, MI 48126 Phone: 313-581-6009

Dr. Walter Joseph Talamonti, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 American Rd, Whq Suite 513, Dearborn, MI 48126 Phone: 313-323-9210    Fax: 313-390-0354

Dr. Lisa Kae Beers, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 American Rd, Suite 204, Dearborn, MI 48126 Phone: 313-322-1131    Fax: 313-845-8659

News Archive

Study shows effectiveness of mix-and-match COVID-19 vaccines

People who had received a first dose of the Oxford-AstraZeneca COVID-19 vaccine and received an mRNA vaccine for their second dose had a lower risk of infection compared to people who had received both doses of the Oxford-AstraZeneca vaccine.

Gingrich: Romney's Mass. health plan too 'liberal' for S.C. GOP

On Face The Nation, Gingrich said South Carolina voters also realized how "liberal" Romney was when he governed Massachusetts, particularly his health care plan. "Clearly, he was way to the left" of South Carolina voters, Gingrich said.

ACT Biotech's Telatinib receives orphan drug designation from FDA for treatment of gastric cancer

ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company's highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.

COVID-19 pandemic has worsened global maternal and perinatal outcomes

Immediate action is required to preserve safe maternity care worldwide, as the COVID-19 pandemic worsens global maternal and perinatal outcomes, especially in low- and middle- income countries (LMICs), a study warns.

New data reveals the effect of lockdowns on air pollution levels

One consequence of the coronavirus pandemic has been global restrictions on mobility. This, in turn, has had an effect on pollution levels in the atmosphere.

Read more Medical News

› Verified 5 days ago